Heparin vs. lepirudin flushes in preventing withdrawal occlusion of tunneled, open-ended venous access devices: a blinded, randomized, clinical trial

Trial Profile

Heparin vs. lepirudin flushes in preventing withdrawal occlusion of tunneled, open-ended venous access devices: a blinded, randomized, clinical trial

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Apr 2006

At a glance

  • Drugs Lepirudin (Primary) ; Heparin
  • Indications Catheter thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top